Consumer Oxygen Equipment Market - Forecasts from 2021 to 2026
|出版商||Knowledge Sourcing Intelligence||商品編碼||1023214|
|出版日期||內容資訊||英文 109 Pages
|消費者用氧氣設備市場:2021年至2026年的預測 Consumer Oxygen Equipment Market - Forecasts from 2021 to 2026|
|出版日期: 2021年07月09日||內容資訊: 英文 109 Pages||
The global consumer oxygen equipment market is projected to grow at a CAGR of 8.04% during the forecast period to reach US$11.812 billion by 2026, from US$6.873 billion in 2019. The prime reason driving the market growth during the forecasted period is the rising demand for oxygen for medication purposes. An increasing level of pollution coupled with an unfavorable environment has significantly increased instances of lung-related diseases and breathing disorders. Patients suffering from cancer, chronic obstructive pulmonary disease (COPS), or any other disorders find it difficult to breathe since their lungs are unable to extract enough oxygen from the air they breathe in. These patients then rely on oxygen equipment for aid. Further, technological innovation has resulted in the manufacturing of portable oxygen concentrators which are easier to carry, increasing the market scope significantly.
Rising cases of asthma and lung cancer have created a significant market demand for oxygen equipment for better aid and health.
Asthma and lung cancer patients are the prime users of consumer oxygen equipment. Rising instances of these chronic diseases are the prime reason driving the market demand for oxygen equipment. Research by the World Health Organization (WHO) found that 2.2 million new lung cancer cases were discovered in 2020, the second highest in the year. However, lung cancer was the leading reason for cancer-related deaths, taking 1.8 million lives. Increasing pollution coupled with rising consumption of tobacco is anticipated to increase the cases of cancer and other lung-linked chronic diseases in the coming years, requiring medical attention for prevention and treatment. Hence, the oxygen equipment market will observe significant market growth during the forecasted period.
The coronavirus is another breathe-linked disease that has severely affected the global economy. The outbreak of the virus has boosted the demand for oxygen equipment at an exponential rate. Coronavirus affects the respiratory functions of the body, making it difficult for the infected patients to breathe and hence causing death. The outbreak of the virus has accelerated the oxygen demand and linked equipment at an exponential level. Particularly during the second wave of the virus which caused more death due to higher name of per day cases and oxygen linked shortage. The limited supply of oxygen and/ or supporting equipment increased the number of preventable fatalities. Hence, to ensure sufficient oxygen and equipment supply, WHO, partnered and distributed over 30,000 concentrators and more than 40,000 oximeters and patient monitors, especially in 37 countries classified as "fragile".
Oxygen Concentrators in a homebound medication system saw a skyrocketing market size amid the pandemic which is anticipated to resume to normal rates during the forecasted period.
Oxygen concentrators are commonly used oxygen equipment by patients in a homebound medication environment. Portal oxygen concentrators are anticipated to dominate the market during the forecasted period. Owing to their portability, ease to carry, and low cost these concentrators are widely adaptable. Further, rising favourability for home medication since it cost less than in-hospital treatment, has significantly inclined the market trends towards concentrators.
During the peak of the virus, hospitals globally observed a boom in the number of patients rushing for treatment and other facilities. However, limitations of beds and other equipment constrained proper treatment. Hence, infected people with the least severity were advised to adopt homebound medication through oxygen concentrators which significantly increased the market scope. Further, skyrocketing cases and limited resources increased the demand for oxygen concentrators in the retail division. However, financial constraints and loss of income amid lockdown and increasing unemployment hindered the market. As support, several international organizations and companies tied up to provide the demand shortage. Hindustan Unilever, for instance, partnered with Portea Medical to supply 4,000 oxygen concentrators in India, to fight against the devastating second wave.
Demand for oxygen equipment boomed in the Asia Pacific region amid the outbreak of the virus. However, the North American consumer oxygen market will have a significant market share during the forecasted period.
Based on geography, the global consumer oxygen equipment market is segmented into North America, South America, Europe, Middle East, and Africa, and the Asia Pacific region. The North American region is projected to hold a significant share in the consumer oxygen equipment industry. the rising instance of lung-related chronic diseases along with better healthcare infrastructure and resources support the market growth during the forecasted period. In the US, lung cancer is the third largest disease-causing cancer-linked death. In 2020, 235,760 new cases were recorded in the country while the diseases caused 131,880 deaths. Rising cases of lung cancer along with other chronic diseases such as asthma and obesity have increased the demand for oxygen equipment in the region.
The Asia Pacific region, however, is projected to show robust demand amid pandemics. A surge in cases of patients was observed, particularly in the second wave of the virus, across the region, especially in India, Singapore, Thailand, and others. The severity of this wave caused a hike in demand for oxygen equipment in the region. The prediction of a third wave has increased the concerns of healthcare authorities and increased the demand for oxygen equipment to reduce covid linked fatalities and deaths.